Arsenic Trioxide in Treating Men With Germ Cell Cancer

Completed · Phase 2

Conditions studied: Extragonadal Germ Cell Tumor, Testicular Germ Cell Tumor

In brief

RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. PURPOSE: Phase II trial to study the effectiveness of arsenic trioxide in treating men who have germ cell cancer that has not responded to previous treatment.

Key facts

Study ID
NCT00036842
Run by
SWOG Cancer Research Network
Starts
2002-04-01
Expected to finish
2007-06-01
Last updated by the study team
2013-06-24

Who can join

Age: 16 and older. Sex: male. Healthy volunteers: not accepted.

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.